Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 12
Submit an article Journal homepage
145
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Unifocal cutaneous blastic plasmacytoid dendritic cell neoplasm with a favorable response following high-dose radiotherapy alone

Martin J. Higginsa Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, AustraliaCorrespondence[email protected]
,
Sean Harropb Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia
,
Stephen Ladec Department of Anatomical Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia
,
H. Miles Princeb Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia;d Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia
,
Christopher McCormacke Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
&
Belinda A. Campbella Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia;d Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia;f Department of Clinical Pathology, The University of Melbourne, Parkville, Australia
Pages 3004-3007 | Received 25 Apr 2022, Accepted 19 Jul 2022, Published online: 29 Jul 2022

References

  • Facchetti F, Petrella T, Pileri SA: Blastic plasmacytoid dendritic cell neoplasm, in Swerdlow SH, Campo E, Harris NL, et al (eds.): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, pp 174–177. Lyon, France, International Agency for Research in Cancer, 2017
  • Petrella T, Comeau MR, Maynadie M, et al. Agranular CD41 CD561 hematodermic neoplasm (blastic NK-cell lymphoma) originates from a population of CD561 precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002;26(7):852–862.
  • Facchetti F, Jones DM, Petrella T. Blastic plasmacytoid dendritic cell neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC; 2008.
  • Guru Murthy GS, Pemmaraju N, Atallah E. Epidemiology and survival of blastic plasmacytoid dendritic cell neoplasm. Leuk Res. 2018;73:21–23.
  • Pagano L, Valentini CG, Grammatico S, et al. Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches. Br J Haematol. 2016;174(2):188–202.
  • Julia F, Petrella T, Beylot-Barry M, et al. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol. 2013;169(3):579–586.
  • Sweet K. Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment. Curr Opin Hematol. 2020;27(2):103–107.
  • Jen EY, Gao X, Li L, et al. FDA approval summary: tagraxofusp-erzs for treatment of blastic plasmacytoid dendritic cell neoplasm. Clin Cancer Res. 2020;26(3):532–536.
  • Pemmaraju N, Lane AA, Sweet KL, et al. Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm. N Engl J Med. 2019;380(17):1628–1637.
  • Tsunoda K, Satoh T, Akasaka K, et al. Blastic plasmacytoid dendritic cell neoplasm: report of two cases. J Clin Exp Hematop. 2012;52(1):23–29.
  • Facchetti F, Cigognetti M, Fisogni S, et al. Neoplasms derived from plasmacytoid dendritic cells. Mod Pathol. 2016;29(2):98–111.
  • Kinoshita-Ise M, Uchida R, Shioiri M, et al. Benefit of electron beam therapy in combination with medium-dose systemic corticosteroid as a palliative treatment for elderly patients with blastic plasmacytoid dendritic cell neoplasm: case report and review of the literature. Clin Exp Dermatol. 2019;44(2):221–224.
  • Ishibashi N, Maebayashi T, Aizawa T, et al. Radiation therapy for cutaneous blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature. Int J Clin Exp Med. 2015;8(5):8204–8209.
  • Stein BL, Williams DM, O'Keefe C, et al. Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes. Haematologica. 2011;96(10):1462–1469.
  • Khanlari M, Yin CC, Takahashi K, et al. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients. Leukemia. 2022;36(5):1343–1350.
  • Menezes J, Acquadro F, Wiseman M, et al. Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm. Leukemia. 2014;28(4):823–829.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.